A carregar...
Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate
Patients with advanced germ cell tumors can be cured with cisplatin-based chemotherapy, but the outcome remains unsatisfactory for patients with relapsed disease, including those patients with refractory disease after bone marrow transplantation. Targeted therapies have changed the standard of care...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2914388/ https://ncbi.nlm.nih.gov/pubmed/20737043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000260901 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|